(Q45752014)

15 December 2017

review article

1 reference

title

Hepatitis C in the patient with human immunodeficiency virus infection (English)

1 reference

15 December 2017

1 reference

Spengler U

1

1 reference

15 December 2017

Rockstroh JK

series ordinal

2

1 reference

15 December 2017

publication date

1 December 1998

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

29

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

1023-1030

1 reference

15 December 2017

Epidemiology of hepatitis C

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Male-to-female transmission of HIV in a cohort of hemophiliacs--frequency, risk factors and effect of sexual counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Sexual and perinatal transmission of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Mother to infant transmission of coinfection by human immunodeficiency virus and hepatitis C virus: prevalence and clinical manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Persistent hepatitis C virus RNA replication in haemophiliacs: role of co-infection with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatitis C virus infection in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Extrahepatic Manifestations of Hepatitis C and the Association with Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Hepatic Histopathology in the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

CD30 and type 2 T helper (Th2) responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Biology of human TH1 and TH2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Therapy of hepatitis C: overview

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

[The therapy of viral hepatitis in HIV-infected patients]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Ribavirin antagonizes the effect of azidothymidine on HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Drug sensitivity of human immunodeficiency virus type 1 isolates after ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980135-9

7 January 2021

10.1016/S0168-8278(98)80135-9

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017